# A Prospective Cohort Study of Primary Dengue Virus Infection in Medellín, Colombia

**Authors:** Andrea Trujillo, Liesbeth Van Wesenbeeck, Lina Salazar, Liliana López, Lotke Tambuyzer, Annemie Buelens, Kim De Clerck, Oliver Lenz, Leen Vijgen, Marnix Van Loock, Guillermo Herrera-Taracena, Iván Darío Vélez, Freya Rasschaert

PMC · DOI: 10.3390/vaccines13070748 · 2025-07-12

## TL;DR

This study tracked dengue virus infections in a group of people in Medellín, Colombia, finding that 2% became infected, but most didn't show symptoms.

## Contribution

The study establishes a cohort in a dengue-endemic area as a proxy for travelers and quantifies primary DENV infection rates, including asymptomatic cases.

## Key findings

- 2% of participants had laboratory-confirmed dengue virus seroconversion.
- Less than 1% of participants reported febrile illness consistent with dengue.
- The cohort served as a proxy for travelers in dengue-endemic regions.

## Abstract

Background: The evaluation of antiviral or vaccination strategies for the prevention of dengue infections in a traveler population would require extensive and complex studies. This prospective study aimed to identify a cohort of dengue naïve participants living in Medellín, a dengue endemic area, as a proxy for travelers and to determine the incidence of primary dengue virus (DENV) infection (symptomatic and asymptomatic) in this cohort. In Colombia, epidemic dengue waves occur every 3–4 years, with infected Aedes mosquitoes present in ~80% of the territory, including Medellín. Methods: Participants > 16 years of age, living in Medellín, were screened for anti-DENV immunoglobulin G (IgG). DENV seronegative participants were enrolled in this study. A serological anti-DENV survey was performed, with semiannual sample collections for up to 2 years. Acute DENV infections were evaluated by monitoring fever and testing for DENV nonstructural protein 1 and/or RNA. Results: Of the 4885 screened participants, 3008 participants (62%) were DENV seronegative and enrolled. Among them, 2263 (75%) completed this study, and 2644 (88%) had at least one serosurvey visit after baseline. Of those, 52 (2%) had laboratory-confirmed DENV seroconversion, and 19 (<1%) had febrile illness, but none had laboratory-confirmed DENV infection. Conclusions: This study identified a cohort of predominantly students, seronegative at study start, living in Medellín and serving as a proxy for a prospective DENV infection traveler population. Laboratory-confirmed primary DENV infection was found in 2% of participants, with <1% reporting febrile illnesses, meeting the WHO criteria for probable clinical dengue cases.

## Linked entities

- **Diseases:** dengue (MONDO:0005502)

## Full-text entities

- **Diseases:** febrile illness (MESH:D005334), infections (MESH:D007239), DENV seroconversion (MESH:D003715)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12300838/full.md

---
Source: https://tomesphere.com/paper/PMC12300838